Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03759847 · ClinicalTrials.gov registry record · NA

Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT03759847 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03759847, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to track their fluid intake throughout the course of the day. This protocol is designed to test the safety and efficacy of this app, followed by use of the app in patients with large fluid weight gains between HD sessions. In the Vanguard phase, patients without large interdialytic fluid gains (less than 4%) will use the app to to determine the association between the interdialytic weight gain and the fluid consumed as recorded by use of the app for each interdialytic period. The app will be modified, if needed, prior to initiation of the full scale trial.

Interventions

  • OTHER Survey
  • OTHER Fluid intake app

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2019-01-23
Est. Completion 2023-09-21
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT03759847

The ClinicalTrials.gov registry entry for NCT03759847 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Survey is the first listed.

NCT03759847 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03759847 about?

NCT03759847 is a clinical study titled "Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis". Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to track their fluid intake throughout the course of the day. This protocol is designed to test the safet...

What is the current status of trial NCT03759847?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-01-23. Estimated completion is 2023-09-21.

What interventions are being tested in trial NCT03759847?

The interventions under investigation include: Survey (OTHER), Fluid intake app (OTHER).

Who is sponsoring clinical trial NCT03759847?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.